|View printer-friendly version|
|December 16, 2004 5:25 p.m.|
|Teva Launches Quinapril Hcl Tablets; Pursuant To Agreement With Ranbaxy|
Jerusalem, Israel, December 16, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Ranbaxy Pharmaceuticals Inc. announced today that Teva has begun commercially shipping Quinapril HCl Tablets, 5 mg, 10 mg, 20 mg and 40 mg, manufactured pursuant to Ranbaxy's ANDA No. 076607, which received final FDA approval. The product will be sold under the Teva label and marketed by Teva USA.